跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Floxlevo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Floxlevo
Approved
STANDARD
Floxlevo
Akums Drugs & Pharmaceuticals Ltd. (Plant III-Injectables)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
701b543f940963c8
Company
Akums Drugs & Pharmaceuticals Ltd. (Plant III-Injectables)
Type
Standard
Approval Details
Approval Id
701b543f940963c8
Drug Approval Philippines Name
Floxlevo
Product Name
Floxlevo
Registration Number
DRP-3937-02
Brand Name
Floxlevo
Generic Name
Levofloxacin (As Hemihydrate)
Dosage Form
Solution For Intravenous Infusion
Dosage Strength
5 mg/5mL (500mg/100mL)
Manufacturer
Akums Drugs & Pharmaceuticals Ltd. (Plant III-Injectables)
Importer
Ambica International Corporation
Distributor
Detoxicare Philippines, Inc. Unit
Issuance Date
27 May 2022
Expiry Date
04 September 2027
Pharmacologic Category
Antibacterial (Quinolone)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
701b543f940963c8
Type
Standard
Back to Philippines FDA Approvals